Market Overview

Clovis Oncology, Inc. (NASDAQ: CLVS)

5.20 -0.09 (-1.61%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/22/20HC Wainwright & Co.ReiteratesBuy29.0
5/20/20SVB LeerinkMaintainsUnderperform4.0
5/18/20HC Wainwright & Co.MaintainsBuy33.0
5/06/20H.C. WainwrightReiteratesBuy29.0
4/27/20SVB LeerinkDowngradesUnderperform5.0
4/09/20B of A SecuritiesDowngradesUnderperform6.0
1/23/20B of A SecuritiesMaintainsNeutral10.0
11/19/19Evercore ISI GroupDowngradesIn-Line8.0
10/08/19Goldman SachsMaintainsSell3.0
9/24/19SVB LeerinkDowngradesMarket Perform

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter